why choose us

Clinical Trials Search

Showing 11,290 of 132,366 result(s)
An Open Label, Single-arm, Multicenter Phase Ib;II Study to Evaluate the Safety and Efficacy of T-Dxd in Combination With Ramucirumab as a 2nd Line in Patients With HER2 Low Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma

Status: NOT_YET_RECRUITING

Condition: Gastric Cancer

Interventions:

Phase Ib will use a standard 3+3 scheme with the planned doses of T-DXd (4.4~6.4 mg;kg) once every 3 weeks in combination with Ramucirumab 8mg

Date: 2023-05-31

Perioperative Parameter and Treatment Outcomes of ECIRS in Asia

Status: NOT_YET_RECRUITING

Condition: Renal Stone

Interventions: Endoscopic Combined Intrarenal Surgery

Date: 2023-05-31

Effectiveness and Safety of New Oral Antivirals for COVID-19

Status: Completed

Condition: COVID-19

Interventions: Nirmatrelvir;ritonavir

Date: 2023-05-31

Q Angle in Static and Dynamic Postures

Status: Completed

Condition: Quadriceps Muscle

Interventions: Q angle evaluation in two different static postures (upright and supine position) and dynamic posture during the midstance phase of the gait

Date: 2023-05-31

Analysis of T- and B-Cell Subpopulations in Membranous Nephropathy

Status: Completed

Condition: Membranous Nephropathy

Interventions:

Date: 2023-05-31

TQB2223 Injection in Combination With Penpulimab in Patients With Advanced Cancers

Status: Completed

Condition: Advanced Cancer

Interventions: TQB2223 is an anti lymphocyte activation gene-3 (LAG-3) antibody.
Penpulimab Injection is an anti-PD-1 antibody.

Date: 2023-05-31

Tourniquet Use in Anterior Cruciate Ligament Repair

Status: NOT_YET_RECRUITING

Condition: ACL - Anterior Cruciate Ligament Deficiency

Interventions: Patients undergoing ACL reconstruction with or without a tourniquet

Date: 2023-05-31

EFS of the DUO System for Tricuspid Regurgitation (TANDEM II)

Status: NOT_YET_RECRUITING

Condition: Tricuspid Regurgitation

Interventions: Reduction of tricuspid regurgitation through a transcatheter approach

Date: 2023-05-31

Management of ADHD in Autism Spectrum Disorder

Status: NOT_YET_RECRUITING

Condition: ADHD

Interventions:

Amphetamine (AMP) medication names: Adderall, Adderall XR, Adzenys ER, Adzenys XR-ODT, Dayanavel XR, Dexedrine (spansule), Dexedrine (tablet), Myda

Date: 2023-05-31

Evaluating Mitochondrial Dysfunction in Patients With Neurofibromatosis Type 1

Status: Completed

Condition: Neurofibromatosis 1

Interventions: • An additional 10 mL of blood will then be drawn for mitochondrial testing purposes.

Date: 2023-05-31